Showing results (61-70 of 882) with videos related to
Sort By:
Pageof 89
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|May 16, 2019
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testingMartin K Stiles, Laurent Fauchier, Carlos A Morillo, et al.Chest|April 12, 2014
Relationship of the SAMe-TT₂R₂ score to poor-quality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillationGregory Y H Lip, Ken Haguenoer, Christophe Saint-Etienne, et al.Current Problems in Cardiology|February 16, 2026
Prognostic impact of vascular disease in patients with atrial fibrillation: The Loire Valley Atrial Fibrillation ProjectAmeenathul M Fawzy, Arnaud Bisson, Gregory Y H Lip, et al.Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|January 22, 2020
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testingMartin K Stiles, Laurent Fauchier, Carlos A Morillo, et al.European Journal of Heart Failure|February 11, 2005
QT dispersion in nonischemic dilated cardiomyopathy. A long-term evaluationLaurent Fauchier, Julien Douglas, Dominique Babuty, et al.Journal of Arrhythmia|July 12, 2019
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testingMartin K Stiles, Laurent Fauchier, Carlos A Morillo, et al.Thrombosis and Haemostasis|September 2, 2016
Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists. Meta-analysis of observational analysesWalid Darwiche, Theodora Bejan-Angoulvant, Denis Angoulvant, et al.Polish Archives of Internal Medicine|February 12, 2026
Impact of sodium glucose co-transporter 2 inhibitors on bleeding, hospitalizations and other adverse outcomes in atrial fibrillation patients with and without diabetesAmeenathul M Fawzy, Arnaud Bisson, Laurent Fauchier, et al.Journal of the American College of Cardiology|August 20, 2011
Device therapy in heart failure patients with chronic kidney diseaseLeon A Cannizzaro, Jonathan P Piccini, Uptal D Patel, et al.Journal of the American College of Cardiology|August 30, 2023
Ablation to Reduce Atrial Fibrillation Burden and Improve Outcomes: JACC Review Topic of the WeekHannah T Schwennesen, Jason G Andrade, Kathryn A Wood, et al.Pageof 89